Sathit Pichyangkul Selected Research

Merozoite Surface Protein 1 (MSA1)

1/2016	Antibody profiles to plasmodium merozoite surface protein-1 in Cambodian adults during an active surveillance cohort with nested treatment study.
4/2007	Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sathit Pichyangkul Research Topics

Disease

11	Malaria 01/2020 - 04/2004
10	Infections 01/2020 - 04/2004
5	Periodontitis 01/2018 - 06/2002
4	Falciparum Malaria (Plasmodium falciparum Malaria) 06/2015 - 04/2004
4	Influenza in Birds (Avian Flu) 01/2014 - 10/2007
3	Human Influenza (Influenza) 11/2015 - 01/2013
3	Parasitemia 09/2011 - 03/2005
1	Inflammation (Inflammations) 01/2018
1	Bone Resorption 01/2016
1	Gingivitis 01/2016
1	Viremia 10/2013
1	Virus Diseases (Viral Diseases) 08/2010
1	Parasitic Diseases (Parasitic Disease) 04/2007
1	Hypersensitivity (Allergy) 05/2006
1	Sepsis (Septicemia) 08/2004
1	Bacteremia 08/2004
1	Melioidosis 08/2004
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 05/2004

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2018 - 06/2002
5	VaccinesIBA 01/2017 - 03/2005
4	AntigensIBA 01/2016 - 06/2003
4	Proteins (Proteins, Gene)FDA Link 01/2013 - 03/2005
3	AntibodiesIBA 01/2016 - 09/2009
3	LigandsIBA 01/2016 - 04/2004
3	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2008 - 04/2004
2	Merozoite Surface Protein 1 (MSA1)IBA 01/2016 - 04/2007
2	artenimol (dihydroartemisinin)IBA 01/2016 - 06/2015
2	piperaquineIBA 01/2016 - 06/2015
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2020
1	InterferonsIBA 01/2018
1	Bacterial AntigensIBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	InterleukinsIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	B-Cell Activating FactorIBA 01/2016
1	interleukin-21 (interleukin 21)IBA 01/2016
1	HLA-DR Antigens (HLA-DR)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	NucleoproteinsIBA 11/2015
1	Hemagglutinins (Hemagglutinin)IBA 11/2015
1	artemisinin (artemisinine)IBA 06/2015
1	Antimalarials (Antimalarial Agents)IBA 06/2015
1	Primaquine FDA Link 06/2015
1	Neutralizing AntibodiesIBA 10/2013
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2013
1	Ligases (Synthetase)IBA 04/2012
1	Messenger RNA (mRNA)IBA 04/2012
1	2',5'-oligoadenylate (PAPAPA)IBA 04/2012
1	Protein Kinases (Protein Kinase)IBA 04/2012
1	Antiviral Agents (Antivirals)IBA 04/2012
1	DefensinsIBA 04/2012
1	Small Interfering RNA (siRNA)IBA 04/2012
1	Secretory Leukocyte Peptidase InhibitorIBA 04/2012
1	CPG-oligonucleotideIBA 09/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2010
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2010
1	Interleukin-4 (Interleukin 4)IBA 03/2007
1	DNA (Deoxyribonucleic Acid)IBA 05/2006
1	Peptides (Polypeptides)IBA 05/2006
1	Malaria VaccinesIBA 03/2005
1	OligodeoxyribonucleotidesIBA 08/2004
1	CpG ODN 1826IBA 08/2004
1	Phosphates (Orthophosphate)IBA 05/2004

Therapy/Procedure

1	Chemoprevention 01/2016
1	Therapeutics 06/2015
1	Aftercare (After-Treatment) 03/2007